Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.60 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.60 |
| ▸ | MAOA | P21397 | 1/20 | 0.60 |
| ▸ | APP | P05067 | 1/20 | 0.58 |
| ▸ | ACHE | P22303 | 10/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5690118 | 0.87 | MAOB (0.60) | MAOBABCB1MAOAAPPACHE | |
| SCHEMBL29598843 | 0.87 | MAOB (0.60) | MAOBABCB1MAOAAPPACHE | |
| SCHEMBL5692074 | 0.87 | MAOB (0.60) | MAOBABCB1MAOAAPPACHE | |
| SCHEMBL17439336 | 0.85 | MAOB (0.64) | MAOBABCB1MAOAAPPACHE | |
| SCHEMBL5691841 | 0.85 | MAOB (0.64) | MAOBABCB1MAOAAPPACHE | |
| SCHEMBL16065599 | 0.85 | MAOB (0.64) | MAOBABCB1MAOAAPPACHE | |
| SCHEMBL5690929 | 0.84 | MAOB (0.63) | MAOBABCB1MAOAAPPACHE | |
| SCHEMBL5690830 | 0.83 | MAOB (0.69) | MAOBABCB1MAOAAPPACHE | |
| SCHEMBL8069049 | 0.82 | MAOB (0.64) | MAOBABCB1MAOAAPPACHE | |
| SCHEMBL5690560 | 0.82 | MAOB (0.64) | MAOBABCB1MAOAAPPACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160016860-A1 | METHODS FOR PHOSPHINE OXIDE REDUCTION IN CATALYTIC WITTIG REACTIONS | DUBLIN CITY UNIVERSITY (IE) | 2016-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160016860-A1 | METHODS FOR PHOSPHINE OXIDE REDUCTION IN CATALYTIC WITTIG REACTIONS | DCXR, TECR, PWWP2B | MAOB 242/4885ABCB1 4786/4885MAOA 331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.